Junyu Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Junyu Xiao has a total of 497 co-authors. Here are the top co-authors by number of shared publications:
Shuo Du
State Key Laboratory of Veterinary Public Health Safety, College of Veterinary Medicine, China Agricultural University
20 shared publications- Yunlong Cao
Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China
15 shared publications Zhiying Zhang
School of Life Sciences, Peking University, Beijing, People’s Republic of China
15 shared publicationsTianhe Xiao
Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, People’s Republic of China
14 shared publications- Xiaoliang Sunney Xie
Biomedical Pioneering Innovation Center (BIOPIC), and School of Life Sciences, Peking University, Beijing, China
14 shared publications Ayijiang Yisimayi
Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, People’s Republic of China
13 shared publications
Latest Publications
- Open Access
Structural and evolutionary insights into FcαμR recognition of polymeric immunoglobulins
Polymeric immunoglobulins (pIgs) are central to adaptive immunity in jawed vertebrates. FcαμR is a bispecific pIg receptor that recognizes both IgM and IgA, but the molecular basis has been unclear. Here we determine cryo-EM structures of mammalian FcαμR bound to IgM or IgA and show that FcαμR engages each ligand in a 1:1 stoichiometry, with higher affinity for IgM. The FcαμR-binding site overlaps with those of pIgR, and also with the preferred FcμR-binding site on IgM, yet distinct features distinguish FcαμR from both pIgR and FcμR. Functionally, FcαμR efficiently internalizes both IgM and IgA through a pathway independent of the di-leucine motif. Structures of amphibian pIgR and FcαμR bound to IgM further shed light on the evolutionary diversification of the FcαμR/pIgR family. Together, these findings define the structural basis of FcαμR-mediated pIg recognition and provide a framework for understanding the evolution of pIg receptors.
Open AccessStructural and evolutionary insights into FcαμR recognition of polymeric immunoglobulins
Polymeric immunoglobulins (pIgs) are central to adaptive immunity in jawed vertebrates. FcαμR is a bispecific pIg receptor that recognizes both IgM and IgA, but the molecular basis has been unclear. Here we determine cryo-EM structures of mammalian FcαμR bound to IgM or IgA and show that FcαμR engages each ligand in a 1:1 stoichiometry, with higher affinity for IgM. The FcαμR-binding site overlaps with those of pIgR, and also with the preferred FcμR-binding site on IgM, yet distinct features distinguish FcαμR from both pIgR and FcμR. Functionally, FcαμR efficiently internalizes both IgM and IgA through a pathway independent of the di-leucine motif. Structures of amphibian pIgR and FcαμR bound to IgM further shed light on the evolutionary diversification of the FcαμR/pIgR family. Together, these findings define the structural basis of FcαμR-mediated pIg recognition and provide a framework for understanding the evolution of pIg receptors.
- Open Access
- 16 September 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (38)
Glycans influence IgE and IgG recognition by rodent IgG-Fc receptors
Immunoglobulin E (IgE) drives allergic responses. The IgE-Fc (Fcε) receptor FcεRI plays a critical role in transducing IgE signaling; nevertheless, certain IgG-Fc (Fcγ) receptor (FcγR) can also bind IgE in murine models. Here, we characterize FcγR interactions with IgE and IgG in mice and rats, and report cryoelectron microscopy structures of rat FcγRIV–Fcε, mouse FcγRIV–Fcγ2b, and rat FcγRIIB–Fcε complexes. Together with biochemical analyses, we reveal N-linked glycans as critical determinants of affinity and isotype specificity. Specifically, rat FcγRIV exhibits preferential binding to IgE over IgG, while mouse FcγRIV shows the opposite preference. A unique glycan–glycan interaction involving Asn179 in rat FcγRIV underlies its high-affinity IgE binding, whereas the absence of this glycosylation site in rat FcγRIIB results in attenuated IgE recognition. In contrast, only hypoglycosylated mouse FcγRIV at the equivalent position engages strongly with fucosylated IgG2b. Together, these results provide insights into species-specific IgE- and IgG-mediated immune responses.
- 16 September 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (38)
Open AccessGlycans influence IgE and IgG recognition by rodent IgG-Fc receptors
Immunoglobulin E (IgE) drives allergic responses. The IgE-Fc (Fcε) receptor FcεRI plays a critical role in transducing IgE signaling; nevertheless, certain IgG-Fc (Fcγ) receptor (FcγR) can also bind IgE in murine models. Here, we characterize FcγR interactions with IgE and IgG in mice and rats, and report cryoelectron microscopy structures of rat FcγRIV–Fcε, mouse FcγRIV–Fcγ2b, and rat FcγRIIB–Fcε complexes. Together with biochemical analyses, we reveal N-linked glycans as critical determinants of affinity and isotype specificity. Specifically, rat FcγRIV exhibits preferential binding to IgE over IgG, while mouse FcγRIV shows the opposite preference. A unique glycan–glycan interaction involving Asn179 in rat FcγRIV underlies its high-affinity IgE binding, whereas the absence of this glycosylation site in rat FcγRIIB results in attenuated IgE recognition. In contrast, only hypoglycosylated mouse FcγRIV at the equivalent position engages strongly with fucosylated IgG2b. Together, these results provide insights into species-specific IgE- and IgG-mediated immune responses.
- Open Access
- 17 June 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (25)
FcRL4 is an IgA receptor that primarily binds the joining chain
Immunoglobulin A (IgA) is a crucial component of the human immune system, and its interaction with receptors is essential for immune regulation. Fc-receptor-like 4 (FcRL4) is an IgA receptor that selectively binds systemic IgA containing the joining chain (J-chain). The molecular mechanism of this interaction has remained unclear. Here, we present a cryo-EM structure of FcRL4 complexed with the dIgA core (Fcα dimer and J-chain), revealing a 1:1 binding stoichiometry. FcRL4 primarily interacts with the J-chain but can nevertheless discriminate against J-chain-containing IgM through an entropic penalty mechanism. Our structure also explains why FcRL4 does not bind secretory IgA, as the secretory component would hinder FcRL4 binding. Functional studies indicate that FcRL4 lacks the ability to internalize IgA or IgA immune complex. These findings provide fresh insights into IgA biology.
- 17 June 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (25)
Open AccessFcRL4 is an IgA receptor that primarily binds the joining chain
Immunoglobulin A (IgA) is a crucial component of the human immune system, and its interaction with receptors is essential for immune regulation. Fc-receptor-like 4 (FcRL4) is an IgA receptor that selectively binds systemic IgA containing the joining chain (J-chain). The molecular mechanism of this interaction has remained unclear. Here, we present a cryo-EM structure of FcRL4 complexed with the dIgA core (Fcα dimer and J-chain), revealing a 1:1 binding stoichiometry. FcRL4 primarily interacts with the J-chain but can nevertheless discriminate against J-chain-containing IgM through an entropic penalty mechanism. Our structure also explains why FcRL4 does not bind secretory IgA, as the secretory component would hinder FcRL4 binding. Functional studies indicate that FcRL4 lacks the ability to internalize IgA or IgA immune complex. These findings provide fresh insights into IgA biology.
- Open Access
- 20 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (8) , eadz5404
Complement C3 recognition by C3 convertases
The complement system plays a fundamental role in immunity, and its dysregulation is implicated in numerous human diseases. Activation of complement occurs through three main pathways: classical, lectin, and alternative; which converge at the central component, component of complement 3 (C3). The classical and lectin pathways use the C4b2a convertase to cleave C3 and initiate complement activation, while the alternative pathway uses the C3bBb convertase, which is further stabilized by properdin. The molecular mechanisms governing C3 recognition by these convertase complexes remain incompletely understood. Here, we present the 3.1-angstrom cryo–electron microscopy structure of the C4b2a-C3 Michaelis complex, alongside 2.9- and 3.1-angstrom structures of the C4b2 zymogen in loading and activation states, elucidating the structural basis for C3 engagement by C4b2a and conformational changes during the classical and lectin pathway convertase maturation. Furthermore, a 2.6-angstrom structure of C3bBb-properdin in complex with C3 uncovers unique substrate-binding features of C3bBb and properdin’s stabilizing role in the alternative pathway. These results offer comprehensive mechanistic insights into complement activation.
- 20 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (8) , eadz5404
Open AccessComplement C3 recognition by C3 convertases
The complement system plays a fundamental role in immunity, and its dysregulation is implicated in numerous human diseases. Activation of complement occurs through three main pathways: classical, lectin, and alternative; which converge at the central component, component of complement 3 (C3). The classical and lectin pathways use the C4b2a convertase to cleave C3 and initiate complement activation, while the alternative pathway uses the C3bBb convertase, which is further stabilized by properdin. The molecular mechanisms governing C3 recognition by these convertase complexes remain incompletely understood. Here, we present the 3.1-angstrom cryo–electron microscopy structure of the C4b2a-C3 Michaelis complex, alongside 2.9- and 3.1-angstrom structures of the C4b2 zymogen in loading and activation states, elucidating the structural basis for C3 engagement by C4b2a and conformational changes during the classical and lectin pathway convertase maturation. Furthermore, a 2.6-angstrom structure of C3bBb-properdin in complex with C3 uncovers unique substrate-binding features of C3bBb and properdin’s stabilizing role in the alternative pathway. These results offer comprehensive mechanistic insights into complement activation.
- Open Access
- 2 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eaeb8865
Human FcRL5 is an Fc receptor that simultaneously engages two IgGs
The Fc receptors play crucial roles in initiating the effector functions of immunoglobulins. FcRL5 is a prominent target in B cell malignancies and has been implicated as a receptor for immunoglobulin G (IgG). However, the molecular mechanism remained unclear. Here, we demonstrate that human FcRL5, but not its mouse counterpart, is a bona fide IgG-Fc (Fcγ) receptor that uniquely requires the presence of two Fcγ molecules in close proximity to form a robust interaction. Cryo–electron microscopy reveals that FcRL5 optimally engages two Fcγ molecules positioned at a 60° angle, with its D1-D2 domains binding to the first Fcγ molecule, while its D3 domain arches over the second Fcγ. This distinctive binding capability enables FcRL5 to specifically recognize IgG immune complexes (ICs), with the binding strength correlating with IgG concentration in the ICs. In addition, we demonstrate that FcRL5 can internalize the IgG polymer and IC. These results shed light on FcRL5 function and reveal a unique Fcγ-FcγR binding mode governed by avidity.
- 2 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eaeb8865
Open AccessHuman FcRL5 is an Fc receptor that simultaneously engages two IgGs
The Fc receptors play crucial roles in initiating the effector functions of immunoglobulins. FcRL5 is a prominent target in B cell malignancies and has been implicated as a receptor for immunoglobulin G (IgG). However, the molecular mechanism remained unclear. Here, we demonstrate that human FcRL5, but not its mouse counterpart, is a bona fide IgG-Fc (Fcγ) receptor that uniquely requires the presence of two Fcγ molecules in close proximity to form a robust interaction. Cryo–electron microscopy reveals that FcRL5 optimally engages two Fcγ molecules positioned at a 60° angle, with its D1-D2 domains binding to the first Fcγ molecule, while its D3 domain arches over the second Fcγ. This distinctive binding capability enables FcRL5 to specifically recognize IgG immune complexes (ICs), with the binding strength correlating with IgG concentration in the ICs. In addition, we demonstrate that FcRL5 can internalize the IgG polymer and IC. These results shed light on FcRL5 function and reveal a unique Fcγ-FcγR binding mode governed by avidity.
- Open Access
- 1 January 2026
- Published by China Engineering Science Press Co. Ltd. in Vita
TCR–CD3 targeting: less is more
By enforcing a strict 1:1 binding stoichiometry with the T-cell receptor, a novel anti-CD3ε antibody 4B1 uncouples TCR engagement from severe cytokine release syndrome, establishing a safer structural blueprint for next-generation T-cell engagers.
- 1 January 2026
- Published by China Engineering Science Press Co. Ltd. in Vita
Open AccessTCR–CD3 targeting: less is more
By enforcing a strict 1:1 binding stoichiometry with the T-cell receptor, a novel anti-CD3ε antibody 4B1 uncouples TCR engagement from severe cytokine release syndrome, establishing a safer structural blueprint for next-generation T-cell engagers.
- 15 December 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (6) , 1261-1272
CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy
Key Points: CFHR3*B haplotype was a susceptibility variant for IgA nephropathy diagnosis by enhancing complement activation. The rs446868A variant in CFHR3*B elevated CFHR3 transcription and was associated with higher circulating FHR3 levels in patients with IgA nephropathy. FHR3241Ser variant enhanced C3b binding and complement activation, accelerating IgA deposition–induced complement activation in IgA nephropathy. Background: Complement activation is involved in IgA nephropathy. We previously identified that genetic deletion of CFHR3 and CFHR1 confers protection against IgA nephropathy by modulating complement activation. In addition, the CFHR3*B haplotype (rs385390C/rs446868A/rs138675433T/rs149352569T) has been linked to elevated CFHR3 transcription and higher risk of atypical hemolytic uremic syndrome. Methods: We evaluated the association between the CFHR3*B haplotype and IgA nephropathy susceptibility by using genetic analysis of 1108 patients with IgA nephropathy and 630 healthy controls. Luciferase activity assays were performed to assess the transcriptional activity of CFHR3*B haplotype. The coding variant rs138675433 (FHR3 241Pro versus FHR3 241Ser ) was assessed using recombinant proteins to determine its effect on complement regulation. Results: The CFHR3*B haplotype and CFHR3*BB genotype were significantly enriched in patients with IgA nephropathy. The CFHR3*BB genotype correlated with lower circulating C3 levels and greater glomerular C3 deposition. Luciferase activity assays demonstrated enhanced transcription activity conferred by the CFHR3*B haplotype, with rs446868 identified as the functional regulatory variant. Patients carrying the CFHR3*BB genotype exhibited elevated circulating FHR3 levels. FHR3 241Ser exhibited significantly enhanced C3b-binding capacity and factor H deregulation activity, promoting accelerated C3 convertase formation and increased hemolysis. Furthermore, FHR3 241Ser augmented IgA deposition–induced complement activation on cultured mesangial cells in a dose-dependent manner. Conclusions: Our results identified CFHR3*B haplotype as a susceptibility variant for IgA nephropathy diagnosis by accelerating complement activation, through rs446868A enhancing transcription activity and rs138675433T augmenting FHR3 function.
- 15 December 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (6) , 1261-1272
CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy
Key Points: CFHR3*B haplotype was a susceptibility variant for IgA nephropathy diagnosis by enhancing complement activation. The rs446868A variant in CFHR3*B elevated CFHR3 transcription and was associated with higher circulating FHR3 levels in patients with IgA nephropathy. FHR3241Ser variant enhanced C3b binding and complement activation, accelerating IgA deposition–induced complement activation in IgA nephropathy. Background: Complement activation is involved in IgA nephropathy. We previously identified that genetic deletion of CFHR3 and CFHR1 confers protection against IgA nephropathy by modulating complement activation. In addition, the CFHR3*B haplotype (rs385390C/rs446868A/rs138675433T/rs149352569T) has been linked to elevated CFHR3 transcription and higher risk of atypical hemolytic uremic syndrome. Methods: We evaluated the association between the CFHR3*B haplotype and IgA nephropathy susceptibility by using genetic analysis of 1108 patients with IgA nephropathy and 630 healthy controls. Luciferase activity assays were performed to assess the transcriptional activity of CFHR3*B haplotype. The coding variant rs138675433 (FHR3 241Pro versus FHR3 241Ser ) was assessed using recombinant proteins to determine its effect on complement regulation. Results: The CFHR3*B haplotype and CFHR3*BB genotype were significantly enriched in patients with IgA nephropathy. The CFHR3*BB genotype correlated with lower circulating C3 levels and greater glomerular C3 deposition. Luciferase activity assays demonstrated enhanced transcription activity conferred by the CFHR3*B haplotype, with rs446868 identified as the functional regulatory variant. Patients carrying the CFHR3*BB genotype exhibited elevated circulating FHR3 levels. FHR3 241Ser exhibited significantly enhanced C3b-binding capacity and factor H deregulation activity, promoting accelerated C3 convertase formation and increased hemolysis. Furthermore, FHR3 241Ser augmented IgA deposition–induced complement activation on cultured mesangial cells in a dose-dependent manner. Conclusions: Our results identified CFHR3*B haplotype as a susceptibility variant for IgA nephropathy diagnosis by accelerating complement activation, through rs446868A enhancing transcription activity and rs138675433T augmenting FHR3 function.
- Open Access
- 7 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (45) , eaea3737
Xenopus IgX informs engineering strategies of IgM and IgG hexamers
Polymeric immunoglobulins are essential components of the immune system in jawed vertebrates. While mammalian immunoglobulin M (IgM) typically forms a pentamer linked by the joining chain (J-chain), Xenopus laevis IgX can assemble into a J-chain–independent polymer. Here, we present the cryo–electron microscopy (cryo-EM) structure of IgX, revealing its hexameric configuration. By incorporating the IgX tailpiece into human IgM, we achieved efficient IgM hexamer formation. Truncating IgM’s natural tailpiece to a range of 11 to 16 residues also substantially enhanced hexamerization efficiency. Furthermore, introducing a shortened IgM tailpiece to IgG resulted in effective IgG hexamer formation. We further show that the engineered IgM and IgG hexamers targeting CD20 demonstrated robust complement-dependent cytotoxicity (CDC) against several B lymphoma cells. In addition, the IgG-Fc hexamer functioned as a decoy, attenuating CDC in cell cultures. These findings deepen our understanding of polymeric immunoglobulin evolution and introduce innovative strategies for the development of IgM- and IgG-based biologics.
- 7 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (45) , eaea3737
Open AccessXenopus IgX informs engineering strategies of IgM and IgG hexamers
Polymeric immunoglobulins are essential components of the immune system in jawed vertebrates. While mammalian immunoglobulin M (IgM) typically forms a pentamer linked by the joining chain (J-chain), Xenopus laevis IgX can assemble into a J-chain–independent polymer. Here, we present the cryo–electron microscopy (cryo-EM) structure of IgX, revealing its hexameric configuration. By incorporating the IgX tailpiece into human IgM, we achieved efficient IgM hexamer formation. Truncating IgM’s natural tailpiece to a range of 11 to 16 residues also substantially enhanced hexamerization efficiency. Furthermore, introducing a shortened IgM tailpiece to IgG resulted in effective IgG hexamer formation. We further show that the engineered IgM and IgG hexamers targeting CD20 demonstrated robust complement-dependent cytotoxicity (CDC) against several B lymphoma cells. In addition, the IgG-Fc hexamer functioned as a decoy, attenuating CDC in cell cultures. These findings deepen our understanding of polymeric immunoglobulin evolution and introduce innovative strategies for the development of IgM- and IgG-based biologics.
- 1 October 2025
- Published by Springer Nature in Nature Machine Intelligence
- Vol. 7 (10) , 1698-1712
An adaptive autoregressive diffusion approach to design active humanized antibodies and nanobodies
- 1 October 2025
- Published by Springer Nature in Nature Machine Intelligence
- Vol. 7 (10) , 1698-1712
An adaptive autoregressive diffusion approach to design active humanized antibodies and nanobodies